Hopp til innhold

Hematologi

Jernmangelanemi

Risks for anaphylaxis with intravenous iron formulations: a retrospective cohort study. (åpner nytt vindu)

Dave CV, Brittenham GM, Carson JL, Setoguchi S

Kilde‎: Ann Intern Med. 2022;175(5):656-64.

Arkiv‎: PubMed 35344378

DOI‎: 10.7326/M21-4009

https://pubmed.ncbi.nlm.nih.gov/35344378/ (åpner nytt vindu)

Canadian expert consensus: management of hypersensitivity reactions to intravenous iron in adults. (åpner nytt vindu)

Lim W, Afif W, Knowles S, Lim G, Lin Y, Mothersill C, Nistor I, Rehman F, Song C, Xenodemetropoulos T

Kilde‎: Vox Sang 2019;114(4):363-73.

Arkiv‎: PubMed 30937914

DOI‎: 10.1111/vox.12773

https://www.ncbi.nlm.nih.gov/pubmed/30937914 (åpner nytt vindu)

Intravenous iron in patients undergoing maintenance hemodialysis. (åpner nytt vindu)

Macdougall IC, White C, Anker SD, Bhandari S, Farrington K, Kalra PA, McMurray JJV, Murray H, Tomson CRV, Wheeler DC, Winearls CG, Ford I; PIVOTAL Investigators and Committees

Kilde‎: N Engl J Med 2019;380(5):447-58.

Arkiv‎: PubMed 30365356

DOI‎: 10.1056/NEJMoa1810742

https://www.ncbi.nlm.nih.gov/pubmed/30365356 (åpner nytt vindu)